Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Amaero Signs $22.8 Million Credit Agreement with Export-Import Bank of the United States
-
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown
-
Introducing Acronis Ultimate 365: Simple, Integrated Microsoft 365 Protection for Managed Service Providers
-
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results
-
U.S. FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis
-
Korro to Present at the TD Cowen 45th Annual Health Care Conference
-
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
-
Flock Safety and Zencity Release National Survey Revealing Rising Consumer Concerns Over Retail Crime & Support for Security Technology
-
GraniteShares Expands YieldBOOST Family with Launch of YSPY and TQQY ETFs
-
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
-
SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
-
Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
-
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
-
Septerna to Present at TD Cowen 45th Annual Health Care Conference
-
iAnthus Expands Presence in Florida with New GrowHealthy Dispensary in Jacksonville
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer
-
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
-
NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update
-
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
-
Intermex Reports Fourth-Quarter and Full-Year Results
-
Freshworks and Unisys Join Forces to Transform IT Service Management for Mid-Market and Enterprise Companies
-
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
-
January 2025: ELFA CapEx Finance Index Shows Demand Pulled Forward from Jan. to Dec.
-
Searching for Spring: New Drinks & App Rewards at The Human Bean
-
Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit
-
Freename partners with Chiliz: .CHZ Domains Are Here
-
MT Højgaard Holding A/S: Reporting of trading in MT Højgaard Holding A/S shares by senior management
-
Transactions by persons discharging managerial responsibilities and/or persons closely associated
-
Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market
-
GOGL – Q4 2024 Presentation
-
Toobit Boosts Security Measures: Introducing AI-Driven Monitoring, Multi-Factor Authentication, and Strengthened Cold Wallet Management
-
Hillman to Present at the Raymond James 46th Annual Institutional Investors Conference
-
Applied Materials to Participate in the Cantor Fitzgerald Global Technology Conference
-
VR Resources Confirms PGE and Nickel-Copper Fertility at Empire Project in Northwest Ontario
-
Amerigo Announces 2024 Results & Quarterly Dividend
-
Orange County Transportation Authority awards contract for 50 zero-emission buses from NFI subsidiary New Flyer
-
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
-
Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases
-
Papa Johns Raises $73,411 for Canadian Nonprofit
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
American Tungsten Announces Closing of Upsized and Oversubscribed Non-Brokered LIFE Offering of Shares
-
DT Midstream Reports Record 2024 Results; Raises Dividend and 2025 Adjusted EBITDA Guidance
-
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
-
Amerigo Announces 2024 Results & Quarterly Dividend
-
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
-
Rekor’s Vehicle Insite Application Deployed to Study Electric Vehicle Movement Across 90 Sites in the Phoenix Metropolitan Area
-
Kelly Establishes Integrated Permanent Hiring Solutions Business Line Across KellyOCG and Sevenstep
-
Colliers ranked among top three commercial real estate brands for eighth consecutive year
-
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
